Effects of Flumazenil on Global Cerebral Flow and Intracranial Pressure During Reperfusion After Incomplete Cerebral Ischaemia;Wirkungen von Flumazenil auf den globalen zerebralen Blutfluß und den intrakraniellen Druck in der Reperfusionsphase nach globaler inkompletter zerebraler Ischämie

Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie

Volumn 23, Issue 3, 1988, Pages 159-162

  Kochs, E ^a   Roewer, N ^a   Peter, A ^a   Schulte am Esch, J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUMAZENIL; MIDAZOLAM;

ANIMAL EXPERIMENT; BLOOD PRESSURE; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; GOAT; INTRACRANIAL PRESSURE; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; REPERFUSION; ANIMAL; ARTICLE; BRAIN CIRCULATION; DRUG EFFECT; PATHOPHYSIOLOGY; PERFUSION;

ANIMAL; BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; ENGLISH ABSTRACT; FLUMAZENIL; GOATS; INTRACRANIAL PRESSURE; PERFUSION;

EID: 0024022784     PISSN: 09392661     EISSN: 14391074     Source Type: Journal    
DOI: 10.1055/s-2007-1001611     Document Type: Article

References (25)

1. Anderson, B., P. A. Jewełl: The distribution of carotid and vertebral blood in the brain and spinal cord of the goat. Q. T. Exp. Physiol. 41 (1956)462–474
2. Carlsson, C., M. Hägerdal, A. E. Kuasik, B. K. Siesjö: The effects of diazepam on cerebral blood flow and oxygen consumption in rats and its synergistic interaction with nitrous oxide. Anesthesiology 45 (1976) 319–325
3. Chiolero, R.L., P. Ravussin, J.P. Anderes, N. de Tribolet, J. Freeman: Midazolam revesal with Ro 15–1788 in patients with severe head injury. Anesthesiology 65 (1986) A 358
4. Daniel, P. M. J. D. K. Dawes, M. M. L. Prichard: Studies of the carotid rete and its associated arteries. Philos, Trans. R. Soc. London. Ser. B 237 (1953) 173–208
5. Darragh, A., R. Lambe, H. Scully, I. Brick: Investigation in man of the efficacy of a benzodiazepine antagonist, Ro 15–1788. Lancet II (1981) 8–10
6. Darragh, A., R. Lambe, M. Kenny, I. Brick: Tolerance of healthy volunteers to intravenous administration of the benzodiazepine antagonist Ro 15–1788. Eur. J. Clin. Pharmacol. 24 (1983)569–570
7. Forster, A., O. Luge, D. R. Morel: Effects of midazolam on cerebral blood flow in human volunteers. Anesthesiology 56 (1982) 453–455
8. Geiler, E., D. Niv, A. Silbiger, P. Halpern, Y. Leykin, V. Rudick, P. Sorkine: Ro 15–1788 a Benzodiazepine antagonist in the treatment of 34 intoxicated patients. Anesthesiology 63 (1985) A 157
9. Geiler, E., P. Halpern, A. Silbiger, D. Niv, P. Sorkine, V. Rudick, B. Belhassen, H. I. Miller: The Use of Anexate (Ro 15–1788) for the Reversal of Benzodiazepine Sedation in Cardiac Patients. Anaesthesist 36 (Suppl.) (1987) 361
10. Gisvold, S. E., P. A. Steen: Drug therapy in brain ischaemia. Br. J. Anaesth. 57 (1985)96–109
11. Hofer, P., G. Scollo-Lavizzari: Benzodiazepine antagonist Ro 15–1788 in self poisoning. Arch. Int. Med. 145 (1985) 663–664
12. Hoffmann-La Roche & Co. Benzodiazepine antagonist Ro 15–1788. Nutley: Investigational Drug Brochure (1985)
13. Hossmann, K. A., P. Kleihues: Reversibility of ischemic brain damage. Arch. Neurol. 29 (1973) 375–382
14. Hossmann, K. A., H. LechtapeGrüter, V. Hossmann: The role of cerebral blood flow for the recovery of the brain after prolonged ischemia. Z. Neurol. 204 (1973) 281–299
15. Ingvar, M., B.K. Siesjö: Cell damage in sustained seizures: Role of local cerebral blood flow and local metabolic rate. J. Cereb. Blood Flow Metabol. 1 (Suppl.) (1981) 98–99
16. Lauven, P. M., H. Schwilden, H. Stoeckel, D. J. Greenblatt: The effects of a benzodiazepine antagonist Ro 15–1788 in the presence of stable concentrations of midazolam. Anesthesiology 63 (1985) 61–64
17. Möhler, H., G. Richards: Agonist and antagonist benzodiazepine receptor interaction in vitro. Nature 294 (1981) 763–765
18. Myers, R. E.: Lactic acid accumulation as a cause of brain edema and cerebral necrosis resulting from oxygen deprivation. In: Korobkin, R., G. Guilleminault (Hrsg.). Advances in Perinatal Neurology. Spectrum Publishers New York (1979) 85–114
19. Norström, C. H., S. Rehncrona, B. K. Siesjö: Restitution of cerebral energy state, as well as of glycolytic metabolites, citric acid cycle intermediates and associated amino acids after 30 minutes of complete ischemia in rats anesthetized with nitrous oxide or phenobarbital. J. Neurochem. 20 (1978) 479–486
20. Nugent M., A. Artru, J. Michenfelder: Cerebral metabolic, vascular and protective effects of midazolam maleate. Anesthesiology 56 (1982) 172–176
21. Raeder J., A. Hole, V. Arnulf, B. H. Grynne: Benzodiazepine Antagonist (Flumazenil) Reversal of Total Intravenous Anesthesia with Midazolam and Alfentanil. Anesthesiology 67 (1987) A 659
22. Roald, O. K., P. A. Steen, K. Stangland, J. F. Michenfelder: The effects of triazolam on cerebral blood flow and metabolism in the dog. Acta Anaesthesiol. Scand. 30 (1986) 223–226
23. Scollo-Lavizzari, G. First clinical investigation of the benzodiazepine antagonist Ro 15–1788 in comatose patients. Eur. Neurol. 22 (1983) 7–11
24. Siesjö, B. K: Cell Damage in the Brain: A speculative Synthesis. J. Cerebral Blood Flow Metabol 1 (1981) 155–185
25. Welsh, F. A., M. D. Ginsberg, W. Rieder, W. W. Budd: Deleterious effect of glucose pretreatment on recovery from diffuse cerebral ischemia in the cat. II. Regional metabolic levels. Stroke 11 (1980) 355–363